MEDTRONIC DIABETES VIRTUAL EVENT

SMART MDI THERAPY

Stay on Track with the First Smart MDI System*
image

INSUlIN PUMP THERAPY

Automated Insulin Delivery for Improved Glucose Control
image

PERSONALIZED SERVICE & SUPPORT

Always by Your Side

image

Join our Presentations: 

Product Theater:
SHARED DECISION WITH DIABETES TECHNOLOGY
Friday, June 25, 2021, 10:00 – 11:00 am ET

SPEAKERS: 
Diana Issacs, PharmD, BCPS, BC-ADM, CDCES, FADCES, Cleveland Clinic
Robert Vigersky, MD, Chief Medical Officer, Medtronic
Ali Dianaty, VP Product Innovation, Medtronic
Janice MacLeod, MA, RD, CDCES, FA, DCES, Clinical Advocacy

 

 Must be registered for ADA, 81st Scientific Sessions to view presentations.

 

 

 

Learning Byte Number One:
TRANSITIONING FROM MDI TO MINIMED™ 770G SYSTEM

SPEAKER:  Laurie Jung, RD, CDCES, Medtronic Diabetes


Learning Byte Number Two:

INPEN™ SMART INSULIN PEN: PRODUCT FEATURES AND OVERVIEW

SPEAKER: Diana Issacs, PharmD, BCPS, BC-ADM, CDCES, FADCES, Cleveland Clinic

 Must be registered for ADA, 81st Scientific Sessions to view presentations.

*

Smart insulin pens connect to a mobile app to provide dosing calculations, reminders and CGM system integration.

Refers to SmartGuard™ Auto Mode. Some user interaction required. Individual results may vary. "Improved" refers for MiniMed™ 770G system. 

Important Safety Information for Guardian™ Connect system:
For continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. Rx Only. Proper mobile device, settings required. See http://bit.ly/GCRisks

Important Safety Information: InPen™
The InPen™ is a home-use reusable pen injector for single-patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self-injection of a desired dose of insulin and for calculating an insulin dose or carbohydrate intake based on user entered data. A healthcare professional must assist in dosage programming of the device prior to use, based on various patient-specific criteria and targets. The InPen™ requires a prescription. For additional product and safety information, please consult the Instructions for Use and bit.ly/InPenSafety.

The virtual booth may include information on products and therapies, and safe and effective uses of those products and therapies, which may not necessarily be approved in accordance with the laws in all countries. Accordingly, attendees must review applicable product labelling for their country for indications and instructions prior to use.

CONTACT

Do you have any questions? We’d like to hear from you.

Contact us